Axcelis Technologies, Inc. $ACLS Shares Sold by Vident Advisory LLC

Key Points

• Vident Advisory LLC has reduced its stake in Axcelis Technologies by 46.5%, owning 18,957 shares worth approximately $942,000 after selling 16,453 shares.
• In contrast, several other hedge funds, including Vanguard Group and Reinhart Partners, have increased their holdings in Axcelis, reflecting a mixed sentiment among institutional investors.
• Axcelis Technologies reported $1.13 earnings per share (EPS) for its latest quarter, surpassing consensus estimates of $0.73, despite a 24.2% decline in revenue compared to the previous year.

Vident Advisory LLC lowered its stake in shares of Axcelis Technologies, Inc. (NASDAQ:ACLS - Free Report) by 46.5% during the first quarter, according to its most recent Form 13F filing with the SEC. The fund owned 18,957 shares of the semiconductor company's stock after selling 16,453 shares during the period. Vident Advisory LLC owned 0.06% of Axcelis Technologies worth $942,000 at the end of the most recent quarter.

Several other hedge funds also recently added to or reduced their stakes in the business. Vanguard Group Inc. grew its position in Axcelis Technologies by 1.0% in the first quarter. Vanguard Group Inc. now owns 4,439,902 shares of the semiconductor company's stock worth $220,530,000 after acquiring an additional 43,768 shares during the period. Reinhart Partners LLC. lifted its stake in shares of Axcelis Technologies by 39.1% in the 1st quarter. Reinhart Partners LLC. now owns 1,441,022 shares of the semiconductor company's stock valued at $71,576,000 after purchasing an additional 404,910 shares during the last quarter. American Century Companies Inc. lifted its stake in shares of Axcelis Technologies by 7.6% in the 1st quarter. American Century Companies Inc. now owns 1,140,495 shares of the semiconductor company's stock valued at $56,648,000 after purchasing an additional 80,399 shares during the last quarter. Boston Trust Walden Corp lifted its stake in shares of Axcelis Technologies by 0.8% in the 1st quarter. Boston Trust Walden Corp now owns 826,332 shares of the semiconductor company's stock valued at $41,044,000 after purchasing an additional 6,216 shares during the last quarter. Finally, BlackBarn Capital Partners LP lifted its stake in shares of Axcelis Technologies by 758.0% in the 1st quarter. BlackBarn Capital Partners LP now owns 480,441 shares of the semiconductor company's stock valued at $23,864,000 after purchasing an additional 424,444 shares during the last quarter. 89.98% of the stock is currently owned by hedge funds and other institutional investors.

Axcelis Technologies Price Performance

ACLS stock opened at $78.79 on Friday. The company has a current ratio of 6.01, a quick ratio of 4.26 and a debt-to-equity ratio of 0.04. The company has a market capitalization of $2.48 billion, a PE ratio of 16.11 and a beta of 1.73. Axcelis Technologies, Inc. has a 12-month low of $40.40 and a 12-month high of $110.17. The business's fifty day moving average price is $75.98 and its 200 day moving average price is $63.44.

Axcelis Technologies (NASDAQ:ACLS - Get Free Report) last posted its quarterly earnings data on Tuesday, August 5th. The semiconductor company reported $1.13 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.73 by $0.40. The firm had revenue of $194.54 million for the quarter, compared to the consensus estimate of $185.15 million. Axcelis Technologies had a return on equity of 16.26% and a net margin of 17.69%.The company's quarterly revenue was down 24.2% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.55 EPS. Axcelis Technologies has set its Q3 2025 guidance at 1.000-1.000 EPS. On average, sell-side analysts anticipate that Axcelis Technologies, Inc. will post 2.55 EPS for the current year.

Analyst Upgrades and Downgrades

Several brokerages have recently commented on ACLS. DA Davidson upped their price target on Axcelis Technologies from $75.00 to $90.00 and gave the company a "buy" rating in a research note on Wednesday, August 6th. B. Riley upped their price target on Axcelis Technologies from $58.00 to $75.00 and gave the company a "neutral" rating in a research note on Wednesday, June 18th. Two equities research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company's stock. According to MarketBeat.com, Axcelis Technologies presently has a consensus rating of "Hold" and an average price target of $90.00.

About Axcelis Technologies

Axcelis Technologies, Inc designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips in the United States, Europe, and Asia Pacific. The company offers high energy, high current, and medium current implanters for various application requirements.

Want to see what other hedge funds are holding ACLS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axcelis Technologies, Inc. (NASDAQ:ACLS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.